Toshiba and Mayo settle MRI patent suit
Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba
Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba last yearin U.S. District Court in Milwaukee (SCAN 2/14/96).
Both parties declined to disclose the terms of the settlement,although they did say that Mayo has licensed the patent to fourother companies besides Toshiba. The patent covers a techniquethat eliminates artifacts caused by flow, motion, and phase aliasingby using a series of saturation pulse sequences that are interleavedwith MRI pulse sequences.
Mayo is also involved in a dispute with Picker Internationalof Cleveland over the patent, according to Mayo attorney WayneBabler of Quarles & Brady in Milwaukee.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
